Two human hSos1 isoforms (Isf I and Isf II; Rojas et al., Oncogene 12, 2291 ± 2300 de®ned by the presence of a distinct 15 amino acid stretch in one of them, were compared biologically and biochemically using representative NIH3T3 transfectants overexpressing either one. We showed that hSos1-Isf II is signi®cantly more eective than hSos1-Isf I to induce proliferation or malignant transformation of rodent ®broblasts when transfected alone or in conjunction with normal H-Ras (Gly12). The hSos1-Isf II-Ras cotransfectants consistently exhibited higher saturation density, lower celldoubling times, increased focus-forming activity and higher ability to grow on semisolid medium and at low serum concentration than their hSos1-Isf I-Ras counterparts. Furthermore, the ratio of GTP/GDP bound to cellular p21 ras was consistently higher in the hSos1-Isf IItransfected clones, both under basal and stimulated conditions. However, no signi®cant dierences were detected in vivo between Isf I-and Isf II-transfected clones regarding the amount, stability and subcellular localization of Sos1-Grb2 complex, or the level of hSos1 phosphorylation upon cellular stimulation. Interestingly, direct Ras guanine nucleotide exchange activity assays in cellular lysates showed that Isf II transfectants consistently exhibited about threefold higher activity than Isf I transfectants under basal, unstimulated conditions. Microinjection into Xenopus oocytes of puri®ed peptides corresponding to the C-terminal region of both isoforms (encompassing the 15 amino acid insertion area and the ®rst Grb2-binding motif) showed that only the Isf II peptide, but not its corresponding Isf I peptide, was able to induce measurable rates of meiotic maturation, and synergyzed with insulin, but not progesterone, in induction of GVBD. Our results suggest that the increased biological potency displayed by hSos1-Isf II is due to higher intrinsic guanine nucleotide exchange activity conferred upon this isoform by the 15 a.a. insertion located in proximity to its Grb2 binding region.
Introduction
Sos guanine nucleotide exchange proteins are known to mediate Ras activation induced by various tyrosine kinase receptors (reviewed in Boguski and McCormick, 1993; Schlessinger, 1993; Downward, 1994; Feig 1994; Quilliam et al., 1995) . A proposed mechanism suggests that recruitment of Sos to the plasma membrane via formation of a complex with Grb2 adaptor proteins is responsible for activation of the mature, membranebound Ras proteins McCormick, 1993; Pawson and Schlessinger, 1993) . The SH3 domains of Grb2 bind to speci®c proline-rich sequences (PCCPPR) located in the C-terminal region of Sos (Chardin et al., 1993; Li et al., 1993b; RozakisAdcock et al., 1993) and the stimulation of receptor tyrosine kinase activity by growth factors accounts for generation of tyrosine phosphate residues anchoring the Sos-Grb2 complex to the membrane through the SH2 domain of Grb2 (Lowenstein et al., 1992) . Rapid association of Grb2-Sos complex to tyrosine-phosphorylated species such as EGF receptor, Shc, IRS-1, and Syp has been demonstrated (Balstensperger et al., 1993; Rozakis-Adcock et al., 1993; Skolnik et al., 1993; Sasaoka et al., 1994; Tauchi et al., 1994) . In this recruitment model, both the cytosolic and membranebound Sos forms are thought to exhibit similar catalytic GEF activity, and no change of Sos catalytic activity is supposed to occur as a consequence of relocation inside the cell. In support of this notion, constitutive or conditional membrane targeting of these exchange factors has been shown to potentiate Ras activation in transfected cells (Aronheim et al., 1994; Quilliam et al., 1994; Holsinger et al., 1995) . However, some recent reports suggest that, irrespective of subcellular location, the intrinsic guanine nucleotide releasing activity of Sos may be dierent before and after stimulation of surface tyrosine kinase receptors (Li et al., 1993a (Li et al., , 1995 (Li et al., , 1996 . Such a notion would be consistent with other reports suggesting that the Cterminal portion of Sos may exert negative regulation over the activity of the whole Sos1 protein (Aronheim et al., 1994; Quilliam et al., 1994; Karlovich et al., 1995; McCollam et al., 1995; Wang et al., 1995; Byrne et al., 1996; Corbalan-Garcia et al., 1998) .
The proline-rich, C-terminal region of Sos contains a number of phosphorylation sites for MAPK and p90 RSK-2 (Cherniack et al., 1994; Corbalan-Garcia et al., 1996; Rozakis-Adcock et al., 1995; Por®ri and McCormick, 1996; Douville and Downward, 1997) . While no change in Sos exchange activity has been demonstrated in response to phosphorylation, binding to Grb2 and Shc appears to be altered, and this may play a negative feedback role on the Ras pathway.
Recently, we identi®ed two distinct human Sos1 isoforms (hSos1-Isf I and hSos1-Isf II) with dierent Grb2 binding anity . These isoforms dier only by the presence in Isf II of a 15 amino acid stretch located close the ®rst proline-rich motif required for Grb2 binding. Some human tissues express only one isoform (fetal brain, and adult skeletal muscle, liver, lung and pancreas) whereas others express dierent proportions of both in fetal and adult stages. In vitro binding assays and yeast twohybrid analysis showed that hSos1-Isf II exhibits higher Grb2 anity than hSos1-Isf I .
In this report we generated permanent NIH3T3 cell lines transfected with either isoform, and compared their biological and biochemical properties. Representative cell lines overexpressing Isf I and Isf II isoforms were characterized in terms of their growth and transforming properties as well as their Ras.GTP content, guanine nucleotide exchange activity and amount and location of the Grb2-Sos1 complexes. The signi®cantly higher biological potency exhibited in various biological assays by hSos1-Isf II in comparison to hSos1-Isf I correlated with an intrinsically higher Ras guanine nucleotide exchange activity, in the absence of any signi®cant dierences in the amount or subcellular location of Grb2-Sos1 complexes in the transfectants.
Results

hSos1 isoforms I and II exhibit dierent transforming ability when expressed in NIH3T3 transfectants
To ascertain possible biological dierences between the Isf I and Isf II isoforms of hSos1, we tested the ability of mammalian expression vectors driving expression of either isoform to induce formation of transformed foci after transfection into NIH3T3 cells. Using a speci®c RT ± PCR assay we determined that normal, untransfected NIH3T3 cells expressed only the Sos1 Isf I isoform (not shown). After transfection of these cells with marker-selectable constructs driving expression of the two hSos1 isoforms, we observed that overexpression of the transfected, unmodi®ed full length hSos1 genes consistently and reproducibly produced weak, but quanti®able, transforming activity that was always lower than that of normal ras genes (Figure 1 ). Under conditions where the full length hSos1-Isf I and hSos1-Isf II proteins were overexpressed at similar levels in the transfectants, we observed that hSos1-Isf II always displayed about threefold higher transforming activity than the corresponding hSos1-Isf I constructs (Figure 1 ). The dierence in transforming potency between the isoforms I and II was further manifested in experiments where the hSos1 isoforms were cotransfected with normal ras genes. As shown in Figure 1 , hSos1-Isf I constructs produced only a modest increase in focus formation over the number of foci produced by normal H-ras alone. In contrast, cotransfection of hSos1-Isf II with normal H-ras genes resulted consistently in more than threefold increase over the number of transformed foci produced by normal H-ras alone (Figure 1) .
The expression levels of the transfected hSos1 Isf I and Isf II isoforms were estimated by immunoblot analysis of representative, individually isolated clones of each of the transfections (Figure 2) . When compared to control clone 51 (transfected with empty plasmid vectors) we observed roughly similar levels of overexpression (7 ± 10-fold over endogenous levels) of hSos1-Isf I and hSos1-Isf II in all transfectants resulting from cotransfection of pLTR2(gpt) constructs of either hSos1 isoform along with empty pMexneo vector (Figure 2a) . In contrast, a broader range of expression levels of either isoform was observed in clones cotransfected with either hSos1 isoform (Isf I or Isf II) and normal H-Ras(Gly 12) (Figure 2b ). Whereas some clones expressed high levels of both cotransfected genes (H-Ras and either hSos1 isoform), others showed preferent expression of either one. Notice, for example, clone 27-1 showing highest expression level of hSos1-Isf II and very low levels of normal Ras, or clone 23-2, which displayed highest levels of both hSos1-Isf I and normal Ras (Figure 2b) .
In contrast to the experiments with full length isoforms, we also observed that complete C-terminal truncation of Sos1 (including the area encompassing the 15 amino acid insertion de®ning the isoforms) results in enhanced transforming ability (Figure 1 ). These observations will be further discussed below in the context of oocyte microinjection experiments evaluating the biological activity of the C-terminal region of Sos1. Figure 1 Transforming activity of hSos1 isoforms. NIH3T3 cells were transfected with dierent hSos1 isoform constructs in pLTR2gpt and normal H-ras (G12) constructs in pMEXneo and transformed foci were scored after 2 ± 3 weeks in culture. Position of the DPR deletion is indicated. Using neo and gpt selection as appropriate, we con®rmed that all plasmid DNAs produced similar numbers of marker-selectable colonies. (MC) showed that transfectants overexpressing Isf II were always more responsive (1.5 ± 2-fold) to PDGF treatment than the corresponding Isf I transfectants (Figure 3a) . Similarly, in cotransfections of normal Ras genes with either hSos1 isoform, the highest mitogenic responses were always produced by the contransfectants carrying Isf II (Figure 3a) .
The ability of a number of representative, individually selected, clones to grow in semisolid medium was also tested (Figure 3b) . Interestingly, none of the transfected clones expressing either hSos1 Isf I or Isf II isoform alone were able to grow in soft agar ( Figure   3b ). In contrast, transfectant clones overexpressing both hSos1 (Isf I or Isf II) and normal Ras(Gly12) produced a measurable number of colonies able to grow on soft agar medium (Figure 3b ). The number ( Figure 3b ) and size (Figure 3c ) of colonies produced by those cotransfectants was signi®cantly higher than those of clones only transfected with normal Ras, suggesting a cooperative eect between the hSos1 isoforms and normal Ras to promote anchorage independent growth. Taking into consideration the level of expression of the transfected hSos1 isoforms in each of the clones analysed (Figure 2 ), it was apparent that the clones expressing transfected Isf II exhibited a signi®cantly more pronounced synergism with normal Ras than those cotransfected with Isf I (Figure 3b ). Thus, clone 27-1, expressing highest levels of hSos1-Isf II (and low levels of H-Ras) produced the highest number of colonies growing in soft agar. Notice also that even in clones where the level of Isf II and Ras expression was lower than in Isf I counterparts ( Figure  2b ), the ability to grow in soft agar was still higher in the case of those clones expressing Isf II (Figure 3b) .
The double transfectants able to grow on soft agar were also compared in regards to their growth rate in culture plates and their tumorigenicity in nude mice tumor assays (Figure 4 ). Consistent with the results for growth in soft agar, the double transfectants overexpressing Isf II showed signi®cantly shorter doubling times and higher saturation densities than those expressing Isf I (Figure 4a ), indicating a superior capability of Isf II to activate normal Ras proteins in the cellular context. Subcutaneous inoculation of the same transfected cells into athymic nude mice con®rmed the higher biological potency of Isf II over Isf I. Whereas the tumorigenicity of normal Ras genes was almost nil, transfected cells overexpressing both normal Ras and either hSos1 isoform displayed signi®cant tumorigenic activity (Figure 4a ), indicating a functional interaction between the cotransfected Ras gene and the hSos1 isoforms. Interestingly, and in agreement with the previous growth data, the transfectants harboring the Isf II isoform exhibited higher rates, and faster kinetics, of tumorigenicity than their Isf I counterparts ( Figure 4b ). Four weeks after inoculation all three Isf II clones tested displayed 100% tumorigenicity, whereas only one (clone 23-1) of the Isf I clones showed a similar behavior.
Levels of endogenous Ras activation in NIH3T3 transfectants overexpressing hSos1 Isf I and Isf II
To investigate the molecular basis for the higher biological potency exhibited by the Isf II isoform, we initiated comparative studies of the biochemical activities associated with each of the isoforms in the transfectants. Since Isf II showed a higher ability to cooperate with either endogenous or cotransfected Ras genes in transformation and tumorigenicity assays, we decided to measure the level of Ras.GTP formation in stable transfectants overexpressing either isoform. Figure 5 shows representative results comparing the levels of Ras.GTP in transfected clones 31-1 and 33-2 expressing similar levels of hSos1-Isf I and hSos1-Isf II respectively, (Figure 2a ) under basal (serum starved) and stimulated (fetal bovine serum, 5 min) conditions. As negative and positive controls, clone 51 (harboring empty vectors pMexneo and pLTR2) and H-Ras cells (transformed by transfected Ras(Val 12)) were analysed in parallel under similar conditions. As seen in Figure  5 , all clones responded to serum stimulation by increasing the level of Ras.GTP in comparison to their basal levels. Interestingly, the basal level of Ras.GTP in starved, unstimulated, Isf II-expressing cells was already almost as high as that measured in Isf I-expressing cells after stimulation by serum for 5 min. The Isf I transfectants reached higher level of Ras.GTP content in response to serum stimulation than control clone 51, transfected with empty vectors ( Figure 5 ). Still, stimulation by serum resulted in higher level of Ras.GTP formation in Isf II-expressing cells than in Isf I-expressing cells. These data further demonstrate that hSos1-Isf II is signi®cantly more eective than hSos1-Isf I in promoting endogenous Ras activation in vivo after cellular stimulation by outside signals.
Interaction of cellular Grb2 with Isf I and Isf II isoforms of hSos1 in transfected cells
Using in vitro binding assays with GST-fusion proteins and yeast two-hybrid analysis, we reported previously that hSos1-Isf II exhibited higher Grb2 binding anity than hSos1-Isf I . Here we wished to examine if the higher in vivo potency displayed by hSos1-Isf II to activate Ras under various experimental conditions (see above sections) could be accounted for by an increased amount or stability of cellular Grb2 ± Sos1 complexes, or by dierent subcellular localization of such complexes in the Isf I and Isf II transfectants. Figure 6 shows representative results obtained by analysing the Grb2-Sos1 complexes in clones 31-1 and 33-2, overexpressing, respectively, similar amounts of transfected Isf I and Isf II isoforms of hSos1. Cellular lysates and anti-Sos1 immunoprecipates of those cell lines, obtained before and after serum stimulation (samples taken at 0, 5 and 25 min), were further analysed by Western blotting with either anti-Grb2 antibodies or anti-Sos antibodies ( Figure 6 ). Direct analysis of the cellular lysates demonstrated that the total amounts of Grb2 and hSos1 proteins present in the cellular lysates were similar in both clones analysed. Furthermore, we consistently observed that essentially identical amounts of coimmunoprecipitated Grb2 were detected in both clones, before and after serum stimulation (Figure 6, upper panel) . We also observed in a variety of subcellular fractionation experiments that the time course of distribution of hSos1 proteins between cytosol and the particulate fraction of the cellular lysates was similar for both isoforms (data not shown). Interestingly, the immunoblot analyses with anti-Sos1 antibodies ( Figure 6 , lower panel) demonstrated not only that similar amounts of hSos1 protein existed in all 31-1 and 33-2 samples compared, but also that serum stimulation of both clones resulted in identical, time-dependent reduction in the electrophoretic mobility of the hSos1 isoform proteins in both cases. Sos1 proteins have been reported to serve as phosphorylation substrate for MAPK/p90RSK-2 (Cherniack et al., 1994; RozakisAdcock et al., 1995; Corbalan-Garcia et al., 1996; Douville and Downward, 1997) . The observed reduction in electrophoretic mobility of the isoforms (5 and 25 min samples) in our transfectants is consistent with similar levels of phosphorylation of both isoforms by MAPK after serum stimulation.
Taken together, these data indicate that there are no clear in vivo dierences between the amount and/or stability of cellular Grb2-hSos1 complexes that could explain the dierent Ras activation levels observed in cells transfected with hSos1 isoforms I or II. In addition, the level of Sos1 protein phosphorylation after serum stimulation appears also to be similar for transfectants harboring either hSos1 isoform. Therefore, factors other than an improved in vivo interaction between Grb2 and the C-terminal domains of the hSos1 isoforms are likely to contribute to the higher biological potency exhibited by Isf II.
Measurement of direct guanine nucleotide exchange activity of full length Isf I and Isf II isoforms overexpressed in NIH3T3 transfected cells
The previous data indicated that Isf II is more potent than Isf I to activate Ras and generate Ras.GTP in vivo in transfected cells, but no evidence was found for dierences between Isf I-and Isf II-overexpressing cells Radioactivity in the GTP and GDP spots of TLC chromatograms was quantitated using a Phosphoimager apparatus, and the percentages relative to the guanine nucleotide pool were calculated according to the formula described in Materials and methods. Cell lines analysed included clone 31-1 (cotransfected with pLTR2-hSos1-Isf I and pMexneo) and clone 33-2 (cotransfected with pLTR2-hSos1-Isf II and pMexneo), which express similar levels of hSos1 protein (see Figure 1 ). Clone 51 (harboring pMexneo+pLTR2gpt) and clone H-ras (transformed by H-Ras V12) were used as negative and positive controls, respectively Figure 6 Analysis of Grb2-Sos1 complexes in Isf I and Isf II transfectants. Representative NIH3T3 clones 31-1 (cotransfected with pLTR2-hSos1-Isf I+pMexneo) and 33-2 (cotransfected with pLTR2-hSos1-Isf II+pMexneo), expressing, respectively, similar levels of the transfected hSos1 Isf I and Isf II isoforms (see Figure  2 ), were serum starved and then stimulated with 30% FBS for the times indicated. Anti-Sos1 immunoprecipitates (obtained from 1 mg total protein lysate) or whole cellular lysates (100 mg protein) were then analysed by immunoblotting using speci®c anti-Grb2 and anti-Sos1 antibodies as described in Materials and methods. Position of hSos1 and Grb2 proteins is indicated by the arrows. Ipp, immunoprecipitate. IB, immunoblot regarding the amount and translocation kinetics of Grb2-Sos1 complexes, nor the level of phosphorylation of Sos1 protein. Interestingly, some recent reports (Li et al., 1996) have suggested that, in contrast to the currently prevailing translocation model (reviewed in Schlessinger, 1993; Downward, 1994) , an increase in the intrinsic catalytic activity of Sos1 may suce to account for the activation of Ras by some tyrosine kinase receptors. In view of those reports, we decided to compare the Ras guanine nucleotide exchange (GEF) activity elicited by overexpressed Isf I and Isf II isoforms in transfected NIH3T3 cells.
Lysates from unstimulated and stimulated 31-1 (overexpressing Isf I) and 33-2 (overexpressing Isf II) cells were immunoprecipitated with anti-Sos1 antibodies, and the resulting Isf I or Isf II immunoprecipitates were then analysed for Ras guanine nucleotide exchange activity assay (Li et al., 1993a (Li et al., , 1996 . We consistently observed (Figure 7 ) that the Isf II immunoprecipitates displayed about threefold higher speci®c activity than Isf I immunoprecipitates when comparing their ability to promote the release of GDP bound to Ras under basal, unstimulated conditions. When serum-starved 31-1 and 33-2 cells were stimulated by addition of serum (30%, 10 min) or PDGF (100 ng/ml, 10 min), the catalytic activity of Isf I immunoprecipitates was increased to the level of the basal activity of Isf II immunoprecipitates in unstimulated cells (Figure 7a,b) . In contrast, Isf II immunoprecipitates showed only a slight additional increase in their GEF activity upon serum stimulation (Figure 7a) . Similarly, PDGF treatment activated the catalytic activity of Isf I, but the activity of Isf II exhibited only a marginal increase upon ligand stimulation (Figure 7b ). These results of GEF activity in Isf I and Isf II transfectants paralleled those measuring levels of Ras.GTP in the same cells. The same amounts of Isf and Isf II proteins were immunoprecipitated in all assays, as assessed by immunoblotting analysis of the immunoprecipitates (data not shown), indicating that the increased GEF activity associated with the Isf II immunoprecipitates re¯ects an increased intrinsic speci®c catalytic activity of the Isf II isoform in relation to Isf I. Because there was not signi®cant dierence in both Grb2-hSos1 association and hSos1 membrane localization between the Isf I and Isf II transfectants, the data suggest that the 15 amino acid insertion near the ®rst proline-rich motif of hSos1 causes conformational changes resulting in constitutive activation of the GEF catalytic activity.
Eects of C-terminal domain peptides on hSos1 biological activity
Since the 15 amino acid insert de®ning the hSos1-Isf II isoform appears to be responsible for the increased biological eciency of this isoform in NIH3T3 cells, we decided to use Xenopus oocytes in an eort to obtain additional insights into the functional role of the insertion within the context of the full hSos1 protein.
We injected oocytes with puri®ed, C-terminal, Isf I and Isf II peptides encompassing both the insertion area and the ®rst two SH3-binding sites of both proteins and looked for functional interactions of the injected peptides with GVBD-inducing signaling pathways initiated by insulin or progesterone. The eect of the Isf I and Isf II peptides in this biological system was remarkably parallel to that of the corresponding, full length isoforms transfected in NIH3T3 cells. Thus, whereas microinjection of the Isf I peptide alone did not produce any eect, injection of the Isf II peptide produced slow, but reproducible rates of GVBD in the injected oocytes, and this eect was dose-dependent ( Figure 8a, panel A) . Furthermore, in experiments where insulin-treated oocytes were further injected with the peptides, the Isf II peptide displayed a marked synergism with insulin, accelerating signi®cantly the kinetics of GVBD induction by this hormone ( Figure  8a, panel B) . In contrast, the corresponding Isf I peptide had a much weaker, if any, biological eect on the rate of insulin-induced GVBD (Figure 8a, panel  B) . None of the two isoform peptides cooperated with progesterone in induction of oocyte maturation, a Rasindependent process (Figure 8a, panel C) . On the other hand, treatment with wortmannin of oocytes previously injected with the Isf II peptide resulted in signi®cant inhibition of the rate of GVBD (not shown). These observations support the notion that the signaling pathway aected by the injected Isf II peptide is Ras-and PI3K-dependent. The speci®city of the eects observed with injected Isf II peptide were further supported by additional control experiments. Thus, control injections with buer or the 6x-Hiscontaining, amino terminal peptide present in all the injected peptides did not produce any eect on the oocytes. Similarly, injection of an unrelated peptide spanning the ®rst 597 a.a. stretch of the N-terminal region of Sos1 did not have any eect either.
These results indicated that the injected peptides are speci®cally aecting Insulin/Ras signaling pathways, and suggested that they do so by interacting with some of the intracellular target(s) of endogenous Sos in the oocyte. This is further supported by our observation, using yeast two-hybrid assays, that a short region encompassing the area around the 15 amino acid insertion de®ning Isf II and lacking all canonical sites for Grb2 binding (Chardin et al., 1993; Li et al., 1993b; Rozakis-Adcock et al., 1993) still showed signi®cant level of interaction with Grb2 (Figure 8b ). Since the peptides tested here did not contain the catalytic CDC25-H domain, an interesting hypothesis is that the C-terminal, proline-rich domain (whose biological activity in oocytes is enhanced by presence of the 15 amino acid insertion) may play a regulatory role on the intrinsic overall catalytic activity of the full length hSos1 molecule. Further evidence for such a regulatory role of the C-terminal, proline-rich, region on activity of the whole hSos1 protein, is provided by our observation that deleting the C-terminal portion of the hSos1 molecule (encompassing the area of the insertion de®ning isoforms I and II), did not result in reduction, but rather, in an enhancement of transforming activity, as compared to full length hSos1 Isf I constructs (Figure 1) . The increase in transforming activity of the DPR mutant (Figure 1 ) was evident not only when this construct was transfected alone but also when cotransfected with normal H-ras (Figure 1) . Furthermore, preliminary analysis of the GEF activity in lysates of marker-selected mass cultures transfected with DPR alone (not shown) showed higher levels than those measured in isolated clones transfected with the full length isoforms (Figure 7 ). These observations not only indicate that the C-terminal domain is dispensable for hSos1 transforming activity (Aronheim et al., 1994; Quilliam et al., 1994; Karlovich et al., 1995; McCollam et al., 1995; Wang et al., 1995; Byrne et al., 1996) but also strongly suggest that it exerts a direct down regulation over the catalytic activity of the whole hSos1 molecule (Corbalan-Garcia et al., 1998) .
Discussion
Recent work from this laboratory identi®ed the existence of two distinct human Sos1 isoforms (designated hSos1-Isf I and hSos1-Isf II) diering only by the presence in Isf II of a 15 amino acid stretch located close to the ®rst proline-rich motif required for Grb2 binding. In vitro binding assays using GST-fusion proteins and yeast two-hybrid analysis showed that hSos1-Isf II exhibits significantly higher Grb2 anity than hSos1-Isf I . Here, we decided to analyse whether the two isoforms exhibited also in vivo biological dierences that could be physiologically relevant regarding cellular mechanisms of Ras activation. For this purpose we set out to study possible biological dierences between NIH3T3 cell lines transfected with, and overexpressing, each of the two isoforms. We observed that naõÈ ve NIH3T3 cells express only one of the two isoforms, Isf I. Therefore the biological dierences observed between controls and the variety of transfected NIH3T3 clones analysed can only be attributed to the speci®c hSos1 isoform, or accompanying genes, being overexpressed in each case.
Our transfection experiments showed that, in agreement with other reports , the unmodi®ed, full length hSos1 genes transfected displayed weak, but reproducible, transforming activity when transfected into NIH3T3 cells. More importantly, we observed that the transforming potency of Isf II was signi®cantly higher than that of Isf I. Thus, Isf II displayed about threefold higher transforming activity than Isf I when transfected alone into NIH3T3 cells. Furthermore, contransfection experiments showed that Isf I constructs caused only a modest increase in the number of foci produced by cotransfected normal H-ras genes, whereas cotransfection of Isf II with normal ras genes resulted consistently in more than threefold increase in number of transformed foci obtained with ras alone. (Chardin et al., 1993; Li et al., 1993; Rozakis-Adcock et al., 1993) were subcloned in pEG202 vector and cotransfected with pJG45-Grb2 (containing full length Grb2) into Saccharomyces cerevisiae EGY48 (see Materials and methods for details). Binding anity was estimated by means of b-galactosidase activity assays. The mean+s.d. of three separate experiments is presented These results clearly demonstrated an intrinsically higher biological potency of Isf II over Isf I when acting alone, and also a signi®cantly superior ability of Isf II to interact functionally with normal Ras gene products in vivo.
Further biological characterization of the transfected clones con®rmed the dierences in biological potency observed between the isoforms. Thus, analysis of the growth properties of the transfectants showed that the cotransfectants overexpressing hSos1-Isf II-Ras consistently exhibited higher saturation density and lower cell-doubling times than those overexpressing Isf I. Furthermore, the Isf II-containing clones exhibited higher ability to grow on semisolid medium and at low serum concentration than their hSos1-Isf I-Ras counterparts, and displayed a faster kinetics of tumorigenesis in nude mice assays. Finally, direct measurements of Ras.GTP content in the transfectants showed that Isf II-overexpressing 3T3 cells displayed signi®cantly higher levels of Ras.GTP, both under basal and stimulated conditions. The fact that even under serum-starvation the Isf II transfectants exhibited higher levels of Ras.GTP than their Isf I counterparts con®rms the higher biological potency of Isf II over Isf I.
We reported previously that hSos1-Isf II possesses signi®cantly higher in vitro Grb2 binding anity than Isf I, as judged by direct binding assays using GST fusion proteins and by yeast two-hybrid analysis . In that regard, it was therefore important to examine whether such increased in vitro Grb2 binding ability could account for the higher in vivo potency (to activate Ras under various experimental conditions) shown by hSos1-Isf II in this study. Surprisingly, our direct measurements of Grb2-Sos1 complexes in the transfectants did not yield any signi®cant dierences in vivo between Isf I-and Isf IItransfected clones regarding the amount, stability and subcellular localization of Sos1-Grb2 complex, or the level of hSos1 phosphorylation upon cellular stimulation. These unexpected results indicated that factors other than an improved in vivo interaction between Grb2 and the C-terminal domains of the hSos1 isoforms need to be invoked to account for the higher in vivo biological potency exhibited by Isf II in the transfectants.
In that regard, it is interesting to note recent reports (Li et al., , 1993a (Li et al., , 1995 (Li et al., , 1996 suggesting that, in contrast to the currently prevailing translocation model (reviewed in Schlessinger 1993; Downward 1994) , an increase in the intrinsic catalytic activity of Sos1 may suce to account for the activation of Ras by some tyrosine kinase receptors including NGF, EGF, PDGF and macrophage-stimulating protein receptor. Indeed, our direct comparison of the Ras guanine nucleotide exchange (GEF) activity detectable in lysates of transfected cells overexpressing Isf I and Isf II con®rmed that view. We showed that Isf II transfectants consistently exhibited about threefold higher activity than Isf I transfectants under basal, unstimulated conditions. These observations strongly suggest that the 15 amino acid insertion near the ®rst proline-rich motif of hSos1 Isf II causes overall conformational or allosteric changes in the complete hSos1 molecule, resulting in constitutive up-regulation of its GEF catalytic activity.
A role for hSos1 C-terminal domain in regulating its intrinsic catalytic (GEF) activity?
Xenopus oocyte maturation is a useful experimental model to obtain functional insights on signaling molecules, or domains thereof, which are able to interact with its progesterone-or insulin/Ras-dependent signaling pathways leading to GVBD (Chuang et al., 1993; Muslin et al., 1993; Katzav et al., 1995; Aroca et al., 1996; Font de Mora et al., 1996) . Our microinjection experiments documented that Isf II peptides are biologically more active than Isf I in aecting oocyte maturation, indicating that the injected peptides are speci®cally aecting Insulin/Ras signaling pathways (Deshpande and Kung, 1987; Korn et al., 1987; Gibbs et al., 1989) , and it is likely that they do so by interacting with some of the intracellular target(s) of endogenous Sos1 in the oocyte. These observations suggested that the 15 amino acid insert is responsible for the intrinsic increase in biological potency, probably by producing some structural change of the C-terminal, Pro-rich domain. Since the peptides tested in oocytes did not contain the catalytic CDC25-H domain of hSos1, we speculate that under basal conditions the C-terminal, proline-rich domain may play a regulatory role over the catalytic activity of the overall hSos1 molecule, which has its active site in the CDC25-H domain. This notion is consistent with reports in other biological systems Byrne et al., 1996; Corbalan-Garcia et al., 1998) . Further evidence for such a regulatory role of the C-terminal region was provided by our experiments showing that deletion of the C-terminal portion of the hSos1 molecule, encompassing the region of the insertion distinguishing Isf II from Isf I, resulted in a dramatic increase of the transforming activity exhibited by the full length hSos1. Such an increase in activity raises questions about the currently accepted model of Ras activation through Grb2-mediated recruitment and translocation of Sos to the plasma membrane (reviewed in Schlessinger, 1993; Downward, 1994) and strongly suggests that, under basal conditions, the C-terminal domain exerts a direct downregulation of the overall catalytic activity of full length hSos1 proteins. The presence within this C-terminal region of the 15 amino acid insert de®ning Isf II appears to modulate signi®cantly such down regulatory eect of this region.
Materials and methods
Transfection assays and cell culture conditions NIH3T3 cells (and transfectant clones) were grown in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% calf serum (Colorado Serum Co.). Constructs pLTR2gpt-hSos1 (Isf I) and pLTR2gpt-hSos1 (Isf II) were generated by inserting full length hSos1 (Isf I) and (Isf II) cDNAs in the XhoI ± ClaI site of pLTR2gpt (Di Fiore et al., 1987b) . The DPR constructs were generated by eliminating all C-terminal sequences after a BamH1 site at position 3200 of the hSos1 coding sequences, and adding a termination codon (SpeI linker, Biolabs). The pMexNeo vector and its derivative containing normal and transforming H-ras have been described previously (Benito et al., 1991) . Transfections were performed using the standard calcium phosphate precipitation method (Wigler et al., 1977) . For the dierent conditions of transfection in 10 cm culture dishes, 1 or 4 mg of hSos1 constructs were transfected, alone or in combination with 0.5 or 0.1 mg of normal H-ras. Morphologically transformed foci were scored after 2 ± 3 weeks in culture. Transfected cells were also selected in medium supplemented, as appropriate, with Geneticin (G418, Gibco/BRL, 750 mg/ml) and/or killer HAT (16HAT, 250 mg/ml xanthine, and 2.5 mg/ml mycophenolic acid). Expression of the hSos1 and Ras proteins in mass cultures and selected, stably transfected, clones was measured, respectively, by immunoblotting or immunoprecipitation and immunoblotting, with speci®c antibodies [hSos1: SC256 antiserum, Santa Cruz Biotechnologies; Ras: Y13-2159 and M-90 monoclonal antibodies (Lacal et al., 1986; Sorrentino et al., 1989) ]. As negative controls, vectors pLTR2gpt and pMexNeo, alone or in combination, were transfected under similar conditions.
Immunoprecipitation and immunoblotting analysis
Nearly con¯uent cells were lysed in 1% Triton X-100 buer (50 mM HEPES pH 7.4, 150 mM NaCl, 1.5 mM MgCl 2 , 5 mM EGTA, 1% Triton X-100, 10% glycerol, 10 mg/ml aprotinin and leupeptin, 1 mM PMSF, 1 mM sodium orthovanadate). Immunoprecipitation of Ras proteins was done by incubation of the clari®ed (by centrifugation) cell lysates with Y13-259 Ras monoclonal antibody (12.5 mg/ml) and protein A-Sepharose beads (Pharmacia, Uppsala, Sweden) precoated with rabbit antirat IgG (Cappel) for 3 h at 48C. Analysis of Grb2-Sos1 in vivo complexes was performed with hSos1-(Isf I and Isf II) NIH transfectant clones. Cells were grown in CS (10%)-containing DMEM until 90% of con¯uence (160 mm plates), at which time the medium was removed and cells were refed with FBS (0%)-containing DMEM, 20 mM HEPES pH 7.5, 0.5% BSA (lipid free). After 18 h in starvation conditions FBS (30%)-containing DMEM was added and the cells were lysed at dierent times (0, 5 and 25 min). The cell lysates were clari®ed by centrifugation. Immunoprecipitation of hSos1 proteins was done by incubation of the supernatants with anti-hSos1 monoclonal antibody (Transduction Laboratories, Lexington, KY, USA), and protein A-Sepharose beads precoated with rabbit anti-mouse IgG (Cappel) for 16 h at 48C. In all cases the immune complexes were washed three times with 1% Triton X-100 buer, resuspended in Laemmli sample buer and boiled for 5 min, and the samples were loaded onto SDS-polyacrylamide gels.
For immunoblotting analysis the material on the polyacrylamide gels were transferred to polyvinilidene di¯uoride membranes (Immobilon-P, Millipore) in a Hoeer electroblotting tank for 9 h at 0.7 amp. Filters were blocked for 90 min at room temperature in 5% nonfat dry milk, 16TTBS (50 mM Tris pH 8.0, 150 mM NaCl, 0.05% Tween-20), and probed with anti-Grb-2 monoclonal antibody (Transduction Laboratories, Lexington, KY, USA), with anti-Sos antiserum C-20 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), or with anti-Ras monoclonal antibody M-90 for 2 h at room temperature in 0.5% BSA, 16TTBS. The ®lters were washed ®ve times in 16TTBS, and incubated for 1 h at room temperature with horseradish peroxidase (HRP)-conjugated anti-mouse antibody or HRP-conjugated antirabbit antibody in 16TTBS for enhanced chemiluminescence (ECL) (Amersham, Arlington Heights, IL, USA). Alternatively the immunoblots were processed using 125 I-labeled protein A (Amersham, Arlington Heights, IL, USA) (2.4610 5 cpm) for 30 min, washed extensively, and exposed to Kodak X OMAT-AR ®lm.
[ 3 H]thymidine incorporation asays Incorporation of [ 3 H]thymidine into NIH3T3 cell clones was assayed with cultures that had been seeded at a density of 2610 5 cells/0.2 ml/well in 96-well microtiter dishes precoated with ®bronectin. At con¯uence, the medium was changed to serum-free DMEM supplemented with 30 nM Na 2 SeO 3 and 5 mg/ml transferrin. PDGF-bb (30 ng/ ml) was added as appropriate to the culture 24 h after the switch to serum-free medium. Incorporation of [ 3 H]thymidine (1 mCi/well) was monitored for 6 h beginning 17 h after addition of PDGF-bb. The cells were washed once with Ca 2+ , Mg 2+ -free PBS and twice with 5% TCA. They were solubilized with 0.25 M NaOH and the radioactivity was counted with a liquid scintillation counter.
Cell proliferation and tumorigenicity assays
For analysis of proliferation in semisolid medium (soft agar assay) 10 4 , 10 3 and 10 2 cells were suspended in 0.4% agarose (SeaPlaque; FMC) in FCS (10%)-containing DMEM as described elsewhere (Di Fiore et al., 1987a) . Colonies were stained and scored 25 days later. For analysis of tumor-forming capacity, about 1610 5 to 2.5610 5 cells were injected subcutaneously into athymic nude mice (Heidaran et al., 1990) . Tumor occurrence and size were monitored at least weekly. The measurement of low-serum, doubling time and saturation density was carried out by a modi®cation of previously described methods (Chan et al., 1993) . NIH3T3 transfectants were seeded at a density of 4610 4 cells/60 mm plate in CS (10%)-containing DMEM. Cells were counted 24 h later, and this was considered day 0. The remaining cultures were incubated either in low (0.5%) or high (10%) serumcontaining DMEM and replenished every 2 days. Cells were trypsinized and counted by hemocytometer every 2 days. Some of the cells grown under high serum conditions were allowed to reach con¯uence and were counted 8 days later.
In vivo guanine nucleotide binding analysis
The GTP/GDP ratio of nucleotides bound to cellular p21Ras was quantitated in NIH3T3 transfectant cells labeled homogeneously with 32 P following procedures described previously (Benito et al., 1991; Heidaran et al., 1992) . Con¯uent NIH3T3 cultures in 15-cm-diameter culture dishes were serum-starved overnight, incubated for 1 h in phosphate-free DMEM, and then incubated for an additional 6-h period in the same medium containing 0.5 mCi/ml [ 32 P]orthophosphate (Du Pont-New England Nuclear). To test the eect of serum the cells were stimulated with FBS (30%)-containing DMEM for 5 min. Cells were then washed with cold PBS containing 1 mM sodium orthovanadate and then lysed and scrapped in 0.6 ml of a solution containing 50 mM Tris/HCl pH 7.5, 20 mM MgCl 2 , 150 mM NaCl, 0.5% Nonidet P-40, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml of aprotinin and leupeptin, and 25 mg/ml of anti-Ras monoclonal antibody Y13-259. The lysates were centrifuged at 48C for 5 min. Supernatants were then precleared by shaking with activated charcoal [previously treated with 10 mg/ml bovine serum albumin (BSA) overnight] for 15 min at 48C. Charcoal was removed by centrifugation, and the supernatants were immunoprecipitated with Y13-259 Ras monoclonal antibody (12.5 mg/ml) and protein A beads precoated with rabbit anti-rat IgG. The immune complexes were washed three times with lysis buer and twice with 20 mM Tris/HCl pH 7.5, 20 mM MgCl 2 and then eluted with 1 M KH 2 PO 4 pH 3.4, 5 mM EDTA. The eluate was then heated at 858C for 3 min, centrifuged and spotted (equal counts from each supernatant) onto a TLC sheet of polyethyleneimine-¯uorescent cellulose. The chromatogram was developed with 1 M KH 2 PO 4 pH 3.4, buer as previously described (Gibbs et al., 1987; Satoh et al., 
